S G, S L, C Z, A N, et al. Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience. J Neurol 2021 Jun 26. pii: 10.1007/s00415-021-10663.
PMID: 34189719